Clinical performance of amperometry compared with enzymatic ultra violet method for lactate quantification in cerebrospinal fluid

Diagnosis (Berl). 2020 Aug 31;8(4):510-514. doi: 10.1515/dx-2020-0065. Print 2021 Nov 25.

Abstract

Objectives: The differential diagnosis between acute bacterial meningitis (BM) and viral meningitis (VM) is crucial for treatment and prognosis. Cerebrospinal fluid (CSF) lactate (LA) is considered a good biomarker for differentiating BM from VM. The objective of this study was to compare the clinical performance of amperometry, which is not validated for measurement of LA in CSF samples, with a validated method (enzymatic ultra violet), for their ability to discriminate between acute BM and VM.

Methods: It was a retrospective, descriptive comparative study, 320 CSF reports were included; LA was quantified in CSF using either Dimension AR machine (Dade Behring) or amperometry (RAPID Point 500, Siemens). All samples with bacteria (n=54) or virus (n=139) identified, compared with a control with normal CSF (n=127).

Results: CSF LA levels were comparable for amperometry or enzymatic methods on each group studied, in a wide range of LA levels; it was capable to distinguish BM from VM independent of the method used to quantify.

Conclusions: The findings support the use of the amperometric method in measuring LA concentrations in CSF in a wide range of values. Amperometry is a less expensive method, validated for blood, easily available in small laboratories including in limited resources countries.

Keywords: amperometry; cerebrospinal fluid; enzymatic ultra violet; lactate; meningitis.

MeSH terms

  • Biomarkers
  • Humans
  • Lactic Acid
  • Meningitis, Bacterial* / diagnosis
  • Meningitis, Viral*
  • Retrospective Studies

Substances

  • Biomarkers
  • Lactic Acid